Authors

Latest:

Dr. Friend on the Importance of Work-up for Patients With Multiple Myeloma

Reed Friend, MD, a medical oncologist in hematology and medical oncology, of Levine Cancer Institute and Carolinas HealthCare System, discusses the importance of appropriate work-ups for patients with multiple myeloma.

Reem Karmali, MD

Latest:

Dr. Karmali on the Impact of CAR T-Cell Therapy in DLBCL

Reem Karmali, MD, Feinberg School of Medicine, Northwestern University, discusses the impact of chimeric antigen receptor (CAR) T-cell therapy on the treatment of patients with diffuse large B-cell lymphoma (DLBCL).

Reem Karmali, MD, MS

Latest:

Dr. Karmali on Optimizing Maintenance Therapy in Older Patients With MCL

Reem Karmali, MD, MS, discusses next steps for optimizing maintenance therapy in older patients with mantle cell lymphoma.

Refaat Hegazi, MD, PhD, MPH

Latest:

Dr. Hegazi on Nutrition-Related Toxicities in Oncology

Refaat Hegazi, MD, PhD, MPH, discusses nutrition-related toxicities in oncology.

Reid Cushman, PhD

Latest:

What Is Malware and Why Should I Worry About It?

What should you know about malware, what can you do to protect your computer, and what should you do if your computer becomes infected?

Reinhard Dummer, MD

Latest:

Dr. Dummer on COMBI-AD Trial Results in BRAF-Mutant Melanoma

Reinhard Dummer, MD, of University Hospital Zurich, discusses the results of the phase III COMBI-AD study presented at the 2017 ESMO Congress in patients with stage III BRAF-mutant melanoma.

Reinhard Dummer, MD, UC San Diego Moores Cancer Center

Reinhard Dummer, MD, University of Zurich Hospital

Reinhard G. Dummer, MD, University Hospital of Zurich

Rekha Rao, PhD

Latest:

Potential Challenges in the Future Treatment of Mantle Cell Lymphoma

Rekha Rao, PhD, assistant professor, University of Kansas Medical Center, discusses the challenges that exist in the future of treatment for patients with mantle cell lymphoma (MCL).

Rena D. Callahan, MD

Latest:

Sharing the Latest in Breast Cancer Care With Drs Rena Callahan and Jame Abraham

Jame Abraham, MD, of Cleveland Clinic, and Rena D. Callahan, MD, of UCLA, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in breast cancer presented during the 2024 San Antonio Breast Cancer Symposium.

Renato G. Martins, MD

Latest:

Dr. Martins on Managing Toxicities Associated With Lenvatinib in DTC

Renato G. Martins, MD, medical director of Outpatient General Oncology/Hematology at Seattle Cancer Care Alliance, medical director of Thoracic/Head and Neck Oncology, and professor at the University of Washington School of Medicine, discusses side effects that are associated with lenvatinib (Lenvima).

Renato G Martins, MD, MPH

Latest:

Dr. Martins on Patient Selection for Nivolumab in NSCLC

Renato G. Martins, MD, MPH, medical director, Outpatient General Oncology/Hematology, Thoracic/Head and Neck Oncology, Seattle Cancer Care Alliance, professor, University of Washington School of Medicine, discusses patient selection for nivolumab (Opdivo) as a treatment for patients with nonâ€“small cell lung cancer (NSCLC).

Rene Gonzalez, MD, University of Colorado Melanoma Research Clinics

Renee Ellmers

Latest:

Congresswoman Renee Ellmers Discusses the Cancer Patient Protection Act of 2013

Congresswoman Renee Ellmers (R-NC-02), U.S. House of Representatives, discusses the importance of the Cancer Patient Protection Act of 2013 (H.R. 1416).

Renier Brentjens, MD, PhD

Latest:

Dr. Brentjens Discusses the Goal of Armored CAR T Cells

Renier Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses the goal of armored chimeric antigen receptor (CAR) T cells.

Renier J. Brentjens, MD, PhD

Latest:

Dr Brentjens on Efforts to Expand CAR T-Cell Therapy Beyond B-Cell Malignancies

Renier Brentjens, MD, PhD, discusses the current landscape of CAR T-cell therapy and ongoing efforts to expand its application beyond B-cell malignancies.

Renuka Iyer, MD

Latest:

Dr. Iyer on Treatment of Patients With Lung NETs

Renuka Iyer, MD, associate professor of Oncology, co-director, Liver and Pancreas Tumor Center, section chief for Gastrointestinal Oncology, Roswell Park Cancer Institute, assistant professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, discusses treatment of patients with lung neuroendocrine tumors.

Research Institute

Reshma Jagsi, MD, DPhil

Latest:

Dr Jagsi on the Implications of the IDEA Trial For Patients With Breast Cancer

Reshma Jagsi, MD, DPhil, discusses the implications of the IDEA trial for patients with breast cancer.